Young Lymphoma Patient Finds Therapy In Epic Hike

At 23, Andy Lyon has already gone through multiple cancer diagnoses and treatments. He was first diagnosed with Hodgkin’s lymphoma in 2008 while a first-year student at the University of California, Berkeley, where he studied astrophysics. Tired of treatments, Lyon decided to make the most of his youth and go on an epic trek known as the Pacific Crest Trail, which runs 2,650 miles from Mexico to Canada, all by himself.

Lyon is still about 300 miles out from the finish line, and so far his quest has been running fairly smoothly. His lymphoma flared up near British Columbia, but he is hoping that a quick treatment along the path will get him right back on the trail.

Lyon received chemotherapy the first time he was diagnosed, but after only a year the lymphoma returned. He received a stem cell transplant, but after a 3-month remission, the cancer reappeared in March 2010. The doctors were running out of ideas.

Lyon's 'healing quest'

"They still wanted to do more chemo, but I said, 'No thanks, I’m gonna explore some other options,'" said Lyon in an interview at the Yakima Valley Memorial Hospital. "I kind of went on a healing journey, a healing quest."

Andy (nicknamed Astro for his major at UC Berkeley), set off on an exploration of nature, meditation, alternative nutrition, and a huge hike to get his mind off the chemo and cancer. He describes his decision to hike the Pacific Crest as not "just an idea; that’s what I was going to do. It’s almost like I didn’t have a choice. I knew it was going to happen."

He began his hike on April 7, with only a lightweight backpack, sleeping bad and tent, and food and water. All in all, only about 20 pounds. He has been averaging about 20 miles a day in often-grueling terrain, but even so, Andy claims that the mental challenge was tougher than the physical.

If the hike gets too physically challenging, the Pacific Crest Outfitters in White Pass is providing horses and a wrangler if Andy will need it. He says, "I don’t think I’ll want to ride a horse the entire rest of the trail. I began it walking, I intend to do it walking, and I’d like to finish the trail on my own two feet."

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap